Paper229889
alpha-adrenoceptor mediated inhibition of human fat cell adenylate cyclase.
Kather H and 3 others. Br J Clin Pharmacol, 1979. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. alpha-adrenoceptor mediated inhibition of human fat cell adenylate cyclase. Papers, record 229889. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/229889
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenylyl Cyclase Inhibitors | Major topic |
| Adipose Tissue | Major topic |
| Receptors, Adrenergic | Major topic |
| Receptors, Adrenergic, alpha | Major topic |
| Humans | |
| Norepinephrine |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21,796 | Adrenaline-sensitive adenylate cyclase of human fat cell ghosts: properties and hormone-sensitivity. | Eur J Clin Invest | 1977 | https://conductscience.org/library/papers/21796 | PubMed |
| 2 | 20,550 | Catecholamine-sensitive adenylate cyclase of human fat cell ghosts: a comparative study using different beta-adrenergic agents. | Metabolism | 1977 | https://conductscience.org/library/papers/20550 | PubMed |
| 3 | 216,883 | Relationship between lipolysis, cyclic AMP, and fat-cell size in human adipose tissue during fasting and in diabetes mellitus. | Metabolism | 1979 | https://conductscience.org/library/papers/216883 | PubMed |
| 4 | 206,193 | Adrenoceptors. | Annu Rev Pharmacol Toxicol | 1978 | https://conductscience.org/library/papers/206193 | PubMed |
| 5 | 4,827,395 | A highly sensitive adenylate cyclase assay. | Anal Biochem | 1974 | https://conductscience.org/library/papers/4827395 | PubMed |
| 6 | 4,343,366 | Inhibition of noradrenaline-induced lipolysis in hypothyroid subjects by increased -adrenergic responsiveness. An effect mediated through the reduction of cyclic AMP levels in adipose tissue. | Acta Med Scand | 1972 | https://conductscience.org/library/papers/4343366 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,262,627 | Response of white adipocyte of mouse and rabbit to catecholamines and ACTH. 3. Modified binding properties of beta-adrenoreceptor and its decreased coupling efficiency for adenylate cyclase. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/6262627 | PubMed |
| 6,257,762 | Pharmacological characterizations of adrenergic receptors in human adipocytes. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6257762 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/229889
GET https://conductscience.org/api/papers/v1/229889/authors